unknown
Stage
About
EyePoint Pharmaceuticals develops and commercializes therapeutics for serious retinal diseases, leveraging proprietary Durasert E™ technology for sustained intraocular drug delivery.
Explore EyePoint Pharmaceuticals, Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.